Literature DB >> 8709287

Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence.

M S Freistadt1, K E Eberle.   

Abstract

Poliovirus (PV) is not often described as a monocyte- or macrophage-tropic virus; however, previous work indicated that neurovirulent PV type 1 Mahoney [PV(1)Mahoney] can productively infect primary human monocytes. To determine whether this replication has a functional role in pathogenesis, primary human mononuclear blood cells were infected with pairs of attenuated and neurovirulent strains of PV. Two neurovirulent strains of PV, PV(1)Mahoney and PV(2)MEF-1, replicated faster and to higher titers than attenuated counterparts PV(1)Sabin and PV(2)W-2, respectively, in primary human monocytes, suggesting that this replication may contribute to pathogenesis. PV(3)Leon grew weakly, while PV(3)Sabin, PV(2)Sabin, and PV(2) P712 did not replicate in these cells, perhaps because of their slow replication cycle. In U937 cells, a monocytelike cell line, PV(1)Mahoney replicated but PV(1)Sabin did not, while both grew well in HeLa cells. When molecular recombinants of PV(1)Mahoney and PV(1)Sabin were assessed, a correlation between neurovirulence and the ability to replicate in primary human mononuclear blood cells was found. Surprisingly, infectious centers assays with primary human mononuclear blood cells and U937 cells indicated that despite the lower overall viral yield, more cells are initially infected with the attenuated viruses. These results indicate that there are virulence-specific differences in the ability of PV(1)Mahoney to replicate in monocytes and suggest that there may be factors in monocytes that virulent strains of PV require.

Entities:  

Mesh:

Year:  1996        PMID: 8709287      PMCID: PMC190685          DOI: 10.1128/JVI.70.9.6486-6492.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  VIREMIA IN INFANTS VACCINATED WITH ORAL POLIOVIRUS VACCINE (SABIN).

Authors:  D M HORSTMANN; E M OPTON; R KLEMPFERER; B LLADO; A J VIGNEC
Journal:  Am J Hyg       Date:  1964-01

2.  A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44.

Authors:  M P Shepley; V R Racaniello
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.

Authors:  S R Pollard; G Dunn; N Cammack; P D Minor; J W Almond
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 4.  Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine.

Authors:  J W Almond; G D Westrop; K A Wareham; M A Skinner; D M Evans; D Magrath; G C Schild; P D Minor
Journal:  Biochem Soc Symp       Date:  1987

5.  Cell-free, de novo synthesis of poliovirus.

Authors:  A Molla; A V Paul; E Wimmer
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

6.  Host cell proteins binding to domain IV of the 5' noncoding region of poliovirus RNA.

Authors:  L B Blyn; R Chen; B L Semler; E Ehrenfeld
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.

Authors:  V I Agol; V P Grachev; S G Drozdov; M S Kolesnikova; V G Kozlov; N M Ralph; L I Romanova; E A Tolskaya; A V Tyufanov; E G Viktorova
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

8.  Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.

Authors:  A B Sabin
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

9.  Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2.

Authors:  D C Pevear; C K Oh; L L Cunningham; M Calenoff; B Jubelt
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

10.  HISTOPATHOGENESIS OF MOUSEPOX: III. ECTROMELIA VIRULENCE.

Authors:  J A ROBERTS
Journal:  Br J Exp Pathol       Date:  1963-10
View more
  16 in total

1.  Dendritic cells and macrophages are productively infected by poliovirus.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Enterovirus 71 infection of monocytes with antibody-dependent enhancement.

Authors:  Shih-Min Wang; I-Chun Chen; Ling-Yao Su; Kao-Jean Huang; Huan-Yao Lei; Ching-Chuan Liu
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

4.  Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.

Authors:  Shaukat Khan; Hidemi Toyoda; Melissa Linehan; Akiko Iwasaki; Akio Nomoto; Günter Bernhardt; Jeronimo Cello; Eckard Wimmer
Journal:  J Gen Virol       Date:  2014-04-30       Impact factor: 3.891

5.  A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice.

Authors:  N M Chapman; A Ragland; J S Leser; K Höfling; S Willian; B L Semler; S Tracy
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 6.  Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.

Authors:  Julie K Pfeiffer
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

7.  Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Authors:  Alain Haddad; M Reza Nokhbeh; David A Alexander; Sandra J Dawe; Christine Grisé; Naveed Gulzar; Kenneth Dimock
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 8.  Enterovirus infections of the central nervous system.

Authors:  Ross E Rhoades; Jenna M Tabor-Godwin; Ginger Tsueng; Ralph Feuer
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

9.  Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.

Authors:  Aaron W Kolb; Kyubin Lee; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  PLoS Pathog       Date:  2016-03-10       Impact factor: 6.823

Review 10.  Neurotropic Enterovirus Infections in the Central Nervous System.

Authors:  Hsing-I Huang; Shin-Ru Shih
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.